Literature DB >> 34603987

Enhancement patterns in the venous phase of contrast-enhanced ultrasounds: diagnostic value for patients with solid pancreatic lesions.

Xueqi Chen1, Fengzhi Hao1, Yang Gui1, Jing Zhang1, Li Tan1, Mengsu Xiao1, Qing Zhang1, Hua Meng1, Jianchu Li1, Yuxin Jiang1, Ke Lv1.   

Abstract

BACKGROUND: To observe and assess the diagnostic value of the venous phase enhancement patterns of contrast-enhanced ultrasounds (CEUS) in patients with solid pancreatic lesions that show iso- to hyperenhancement in the arterial phase of the CEUS.
METHODS: Patients who underwent CEUS for pancreatic lesions in the Peking Union Medical College Hospital between April 2017 and August 2019 were identified from the dynamic CEUS imaging database in the hospital. A total of 57 patients with pathologically or clinically diagnosed pancreatic lesions were retrospectively included in this study, and the CEUS images from these patients were evaluated. The enhancement patterns in each phase were analyzed, and each lesion was classified as malignant or benign using a five-point scale of confidence based on morphology, boundary, vascular invasion, blood flow, and enhancement patterns in ultrasound (US) and CEUS images.
RESULTS: Rapid washout in the venous phase of CEUS images was detected in 30 malignant lesions and 4 benign lesions with malignant potential. The specificity for determining malignancy was 77.8%. Continuous isoenhancement with normal pancreatic tissues in the venous phase achieved a high specificity of 95.0% for determining benign lesions. Early hyperenhancement in the arterial phase followed by slow washout in the venous phase showed high specificity of 98.1% for determining metastasis. The diagnostic confidence improved after reviewing CEUS scans (area under the receiver operating characteristic curve was 0.737 for baseline US and 0.910 for CEUS; P=0.056).
CONCLUSIONS: Enhancement patterns in the venous phase of CEUS images were beneficial in the differential diagnosis of solid pancreatic lesions with iso- to hyperenhancement in the arterial phase on CEUS. 2021 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Ultrasonography; contrast media; pancreatic neoplasms; pancreatitis; retrospective studies

Year:  2021        PMID: 34603987      PMCID: PMC8408783          DOI: 10.21037/qims-20-1248

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  27 in total

Review 1.  Ultrasound diagnosis of pancreatic solid tumors.

Authors:  Atsushi Sofuni; Takayoshi Tsuchiya; Takao Itoi
Journal:  J Med Ultrason (2001)       Date:  2019-08-16       Impact factor: 1.314

2.  Guiding and controlling percutaneous pancreas biopsies with contrast-enhanced ultrasound: target lesions are not localized on B-mode ultrasound.

Authors:  Ying Wei; Xiao-Ling Yu; Ping Liang; Zhi-Gang Cheng; Zhi-Yu Han; Fang-Yi Liu; Jie Yu
Journal:  Ultrasound Med Biol       Date:  2015-03-24       Impact factor: 2.998

Review 3.  Use of Ultrasound Contrast Agents in Relation to Percutaneous Interventional Procedures: A Systematic Review and Pictorial Essay.

Authors:  Christian Pállson Nolsøe; Alexander Bjørneboe Nolsøe; Jeanett Klubien; Hans-Christian Pommergaard; Jacob Rosenberg; Maria Franca Meloni; Torben Lorentzen
Journal:  J Ultrasound Med       Date:  2017-12-12       Impact factor: 2.153

Review 4.  Ultrasound-Guided Percutaneous Core Needle Biopsy for the Diagnosis of Pancreatic Disease.

Authors:  Ying Huang; Jingwen Shi; Yun-Yun Chen; Kao Li
Journal:  Ultrasound Med Biol       Date:  2018-03-22       Impact factor: 2.998

Review 5.  Contrast enhanced ultrasound guidance: a new tool to improve accuracy in percutaneous biopsies.

Authors:  Zeno Spârchez; Pompilia Radu; Teodor Zaharia; Gabriel Kacso; Ioana Grigorescu; Radu Badea
Journal:  Med Ultrason       Date:  2010-06       Impact factor: 1.611

Review 6.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

7.  Pancreatic multicenter ultrasound study (PAMUS).

Authors:  Mirko D'Onofrio; Emilio Barbi; Christoph F Dietrich; Masayuki Kitano; Kazushi Numata; Atsushi Sofuni; Francesco Principe; Anna Gallotti; Giulia A Zamboni; Roberto Pozzi Mucelli
Journal:  Eur J Radiol       Date:  2011-04-03       Impact factor: 3.528

8.  Percutaneous ultrasound-guided core needle biopsy of solid pancreatic masses: Results in 250 patients.

Authors:  Guven Kahriman; Nevzat Ozcan; Serap Dogan; Soner Ozmen; Kemal Deniz
Journal:  J Clin Ultrasound       Date:  2016-04-27       Impact factor: 0.910

9.  Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy.

Authors:  S Rickes; K Unkrodt; K Ocran; H Neye; W Wermke
Journal:  Pancreas       Date:  2003-01       Impact factor: 3.327

Review 10.  Do we need contrast agents for EUS?

Authors:  Adrian Saftoiu; Bertrand Napoleon; Paolo Giorgio Arcidiacono; Barbara Braden; Sean Burmeister; Silvia Carrara; Xin Wu Cui; Pietro Fusaroli; Uwe Gottschalk; Michael Hocke; Stephan Hollerbach; Julio Iglesias-Garcia; Christian Jenssen; Masayuki Kitano; Alberto Larghi; Kofi W Oppong; Anand V Sahai; Siyu Sun; Eike Burmester; Milena Di Leo; Maria Chiara Petrone; Erwin Santos; Anthony Y B Teoh; Joo Ha Hwang; Mihai Rimbas; Malay Sharma; Rajesh Puri; Michel Kahaleh; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2020 Nov-Dec       Impact factor: 5.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.